Related Experiment Videos
Platelet and monocyte variables in homocystinuria due to cystathionine-beta-synthase deficiency
A Coppola1, R Albisinni, P Madonna
1Department of Clinical and Experimental Medicine, University of Naples, Federico, Italy.
Insights
Patients with homocystinuria due to cystathionine-beta-synthase deficiency (CBSD) exhibit elevated thromboxane A2 (TXA2) biosynthesis. Platelet and monocyte function do not appear to be the cause of this enhanced TXA2 production in CBSD patients.
Area of Science:
- Biochemistry
- Cardiovascular Biology
- Metabolic Disorders
Background:
- Homocystinuria due to cystathionine-beta-synthase deficiency (CBSD) is linked to increased thromboxane A2 (TXA2) biosynthesis.
- The precise mechanisms driving this enhanced TXA2 production in CBSD remain unclear.
Purpose of the Study:
- To investigate the role of platelet and monocyte variables in the elevated TXA2 biosynthesis observed in CBSD.
- To correlate these cellular functions with thromboxane formation, measured via urinary 11-dehydro-TXB2 (TXM) excretion.
Main Methods:
- Measurement of platelet and monocyte variables in 9 homozygous and 8 heterozygous CBSD patients.
- Quantification of urinary 11-dehydro-TXB2 (TXM) excretion as a marker of TXA2 formation.
- Statistical analysis to evaluate correlations between cellular variables and TXM excretion.
Main Results:
- Homozygous CBSD patients exhibited significantly higher TXM excretion compared to controls (p < 0.001).
- Obligate heterozygous CBSD patients also showed elevated TXM excretion (p < 0.05 vs. controls).
- All assessed platelet and monocyte variables were within normal ranges and did not correlate with TXM excretion (p > 0.05).
Conclusions:
- Abnormalities in platelet and monocyte function are unlikely to be the primary cause of increased in vivo TXA2 biosynthesis in homocystinuria due to CBSD.
- Further research is needed to elucidate the underlying mechanisms of enhanced TXA2 production in this metabolic disorder.
Abstract:
To gain insight into the mechanisms responsible for enhanced thromboxane (TX) A2 biosynthesis in homozygous homocystinuria due to cystathionine-beta-synthase deficiency (CBSD), we measured a series of platelet and monocyte variables in 9 homozygous and 8 obligate heterozygous CBSD patients and evaluated their relationships to thromboxane formation, as reflected by urinary excretion of its major metabolite, 11-dehydro-TXB2 (TXM). Consistent with our previous data, homozygous CBSD patients showed abnormally high TXM excretion (1175 +/- 236 pg/mg creatinine vs. 284 +/- 39 in control subjects; p < 0.001). Significantly higher TXM excretion was also found in obligate heterozygotes (755 +/- 450 pg/mg creatinine; p < 0.05 vs. control subjects). All platelet and monocyte variables fell within the normal range in CBSD patients and none showed a correlation with TXM excretion (p always > 0.05). Our results argue against abnormalities of platelet and monocyte function being responsible for the abnormally high in vivo TXA2 biosynthesis in homocystinuria due to CBSD.